Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
EBS
EBS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EBS News
Emergent BioSolutions Receives FDA Approval for New NARCAN Multipack Configurations
3d ago
Benzinga
Emergent Receives FDA Approval for New NARCAN® Nasal Spray Multipacks
3d ago
Newsfilter
Emergent BioSolutions Receives FDA Approval for New NARCAN® Nasal Spray Multipacks
3d ago
Yahoo Finance
Emergent BioSolutions (EBS) Sued for Insider Trading, Agrees to $900K Settlement
Jan 16 2026
Benzinga
Emergent Biosolutions' Former CEO Sued for Insider Trading, Facing $900,000 Penalty
Jan 15 2026
stocktwits
Emergent BioSolutions (EBS) Receives FDA Approval for New NARCAN Nasal Spray Packaging
Jan 14 2026
NASDAQ.COM
Emergent BioSolutions Launches NARCAN® Carrying Case to Enhance Accessibility
Jan 14 2026
Newsfilter
Emergent BioSolutions (EBS) Makes $100 Million Prepayment, Reducing Debt by 32%
Jan 12 2026
Globenewswire
Emergent BioSolutions (EBS) Makes $100 Million Voluntary Loan Prepayment, Reducing Debt by 32%
Jan 12 2026
Newsfilter
Emergent BioSolutions Secures $21.5 Million Anthrax Vaccine Order from U.S. Department of War
Jan 08 2026
Globenewswire
Emergent BioSolutions Receives FDA Approval for raxibacumab Production in Winnipeg
Dec 12 2025
Newsfilter
Santander to Divest Stake in Polish Subsidiary for Approximately $473 Million Following Erste Group Agreement
Dec 02 2025
WSJ
12 Stocks Poised for Europe's Comeback
Nov 20 2025
Barron's
Searching for a Bargain on a High-Energy Momentum Stock? Check Out Emergent Biosolutions (EBS)
Nov 07 2025
NASDAQ.COM
Monday's Underperformers: Auto Dealerships and Biotechnology Shares
Nov 03 2025
NASDAQ.COM
Cardinal Health Reports Positive Q1 Results, Alongside Guardant Health, Glaukos, C.H. Robinson, and Other Major Stocks Rising on Thursday
Oct 30 2025
Benzinga
Show More News
